# Post-Market Clinical Study to Confirm Safety and Performance of PuraStat Absorbable Haemostatic Material for the Management of Bleeding in Liver Surgery

> **NCT03600168** · — · UNKNOWN · sponsor: **3-D Matrix Europe SAS** · enrollment: 80 (actual)

## Conditions studied

- Liver Resection

## Interventions

- **DEVICE:** PuraStat®

## Key facts

- **NCT ID:** NCT03600168
- **Lead sponsor:** 3-D Matrix Europe SAS
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-02
- **Primary completion:** 2019-09-04
- **Final completion:** 2020-02
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2019-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03600168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03600168, "Post-Market Clinical Study to Confirm Safety and Performance of PuraStat Absorbable Haemostatic Material for the Management of Bleeding in Liver Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03600168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*